Showing results (1-10 of 210) with videos related to
Sort By:
Pageof 21
Cancer Drug Resistance (Alhambra, Calif.)|January 24, 2024
Unlocking antitumor immunity with adenosine receptor blockersVictoria A Remley, Joel Linden, Todd W Bauer, et al.Pancreas|April 19, 2011
Use of a falciform ligament pedicle flap to decrease pancreatic fistula after distal pancreatectomyDustin M Walters, Jayme B Stokes, Reid B Adams, et al.Journal for Immunotherapy of Cancer|March 17, 2016
From bench to bedside a comprehensive review of pancreatic cancer immunotherapyPaul R Kunk, Todd W Bauer, Craig L Slingluff, et al.Biorxiv : the Preprint Server for Biology|April 27, 2026
Increased expression of a subset of genes within reduced copy number regions across multiple cancer typesTiffany A Melhuish, Sara J Adair, Anant Shah, et al.Biosensors & Bioelectronics|April 14, 2023
Supervised learning on impedance cytometry data for label-free biophysical distinction of pancreatic cancer cells versus their associated fibroblasts under gemcitabine treatmentArmita Salahi, Carlos Honrado, John Moore, et al.Surgery|September 10, 2002
Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft modelScott T Kelley, Chandrakala Menon, Donald G Buerk, et al.Biorxiv : the Preprint Server for Biology|February 9, 2026
A simple method for analyzing competitive growth of multiple cell types in xenograft tumorsTiffany A Melhuish, Sara J Adair, Olivia S Pemberton, et al.Biorxiv : the Preprint Server for Biology|February 20, 2025
ERK plays a conserved dominant role in pancreas cancer cell EMT heterogeneity driven by diverse growth factors and chemotherapiesMichelle C Barbeau, Brooke A Brown, Sara J Adair, et al.Biomolecules|July 29, 2025
PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic CancerXiaolong Wei, William J Kane, Sara J Adair, et al.Science Signaling|August 12, 2025
The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cellsMichelle C Barbeau, Brooke A Brown, Sara J Adair, et al.Pageof 21